We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

298 hedge funds and large institutions have $1.04B invested in Takeda Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 65 increasing their positions, 105 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

407% more call options, than puts

Call options by funds: $60.1M | Put options by funds: $11.9M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

17% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 52

2% more funds holding

Funds holding: 292 → 298 (+6)

1% less ownership

Funds ownership: 5.81% → 4.81% (-1%)

31% less capital invested

Capital invested by funds: $1.51B → $1.04B (-$465M)

38% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 105

Holders
298
Holders Change
+6
Holders Change %
+2.05%
% of All Funds
4.59%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
61
Increased
65
Reduced
105
Closed
52
Calls
$60.1M
Puts
$11.9M
Net Calls
+$48.3M
Net Calls Change
+$4.68M

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$69M
2
BCP
BSN Capital Partners
United Kingdom
+$65.6M
3
Goldman Sachs
Goldman Sachs
New York
+$16.8M
4
HT
HAP Trading
New York
+$9.4M
5
BlackRock
BlackRock
New York
+$5.12M

Top Sellers

Rank Fund Capital Flow
1
GCM
Glenview Capital Management
New York
-$133M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$90.4M
3
AIM
ARK Investment Management
Florida
-$79.1M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$21.3M
5
N
Nuveen
North Carolina
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
American Century Companies
76
American Century Companies
Missouri
$843K +$69.4K +4,945 +9%
AAM
77
Advisors Asset Management
Colorado
$812K -$46.6K -3,321 -5%
ECM
78
ExodusPoint Capital Management
New York
$794K +$366K +26,063 +81%
AAIM
79
American Assets Investment Management
California
$777K – – –
Jane Street
80
Jane Street
New York
$768K -$4.3M -306,383 -84%
MIS
81
Morningstar Investment Services
Illinois
$761K +$35.5K +2,529 +5%
Allspring Global Investments
82
Allspring Global Investments
North Carolina
$744K +$766K +54,619 New
Geode Capital Management
83
Geode Capital Management
Massachusetts
$732K +$325K +23,176 +76%
Bank of New York Mellon
84
Bank of New York Mellon
New York
$689K -$148K -10,570 -17%
YCM
85
Yousif Capital Management
Michigan
$668K +$687K +49,010 New
State Street
86
State Street
Massachusetts
$653K -$13.3K -946 -2%
SIA
87
Schechter Investment Advisors
Michigan
$652K +$671K +47,852 New
Millennium Management
88
Millennium Management
New York
$611K +$409K +29,182 +186%
CP
89
Covenant Partners
Tennessee
$596K -$20.9K -1,493 -3%
EVM
90
Eaton Vance Management
Massachusetts
$586K +$25.7K +1,830 +4%
Bank of Montreal
91
Bank of Montreal
Ontario, Canada
$580K -$929K -66,213 -61%
Franklin Resources
92
Franklin Resources
California
$565K -$603K -42,981 -51%
WFI
93
West Family Investments
California
$563K +$206K +14,670 +55%
TFGT
94
TS Financial Group (TSFG)
Illinois
$535K -$19.2K -1,371 -3%
CGH
95
Crossmark Global Holdings
Texas
$483K +$2.38K +170 +0.5%
BFM
96
Boothbay Fund Management
New York
$481K +$160K +11,400 +48%
CS
97
Credit Suisse
Switzerland
$480K -$337K -24,002 -41%
JMPWA
98
JP Morgan Private Wealth Advisors
California
$479K +$72K +5,136 +17%
TC
99
TwinBeech Capital
New York
$468K +$481K +34,316 New
IRC
100
Investors Research Corp
Georgia
$463K +$140K +10,003 +42%
2 3
4
5 6

TAK Hedge Fund Activity: Q4 2021 in Review

298 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q4 2021, worth a combined $1.04B — down 31% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new TAK positions and 52 closed out — a net gain of 9 holders — while 65 added to existing stakes and 105 trimmed.

The largest buyer was Citigroup, adding an estimated $69M. The largest seller was Glenview Capital Management, exiting entirely with an estimated $133M sold.

  • 298 institutional investors held Takeda Pharmaceutical (TAK) as of Q4 2021, up from 292 in Q3 2021.
  • Funds reported $1.04B of Takeda Pharmaceutical stock for Q4 2021, down 31% quarter-over-quarter.
  • 61 funds opened new Takeda Pharmaceutical positions in Q4 2021 and 52 closed out, a net change of +9 holders.
  • The largest Takeda Pharmaceutical buyer in Q4 2021 was Citigroup, an estimated $69M added.
  • The largest Takeda Pharmaceutical seller in Q4 2021 was Glenview Capital Management, an estimated $133M sold.

Based on aggregated 13F filings for Q4 2021.